F
NUVB icon

F3Logic’s Nuvation Bio NUVB Stock Holding History

F3Logic’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,000
Closed -$109K – 247
2021
Q3 		$109K Buy
+11,000
New +$99.7K 0.01% 233

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

F3Logic's NUVB Position: Q4 2021 in Review

F3Logic sold out of Nuvation Bio (NUVB) in Q4 2021, closing a stake of 11,000 shares — an estimated $109K sold.

F3Logic first reported a position in NUVB in Q3 2021 and held it in 1 quarter. The position peaked at $109K in Q3 2021. 105 funds tracked by Wall St. Rank hold NUVB as of Q4 2021.

  • F3Logic reported no remaining Nuvation Bio position as of Q4 2021 after selling out during the quarter.
  • F3Logic sold 11,000 Nuvation Bio shares in Q4 2021, an estimated $109K.
  • F3Logic first reported a position in Nuvation Bio in Q3 2021 and held it in 1 quarter.
  • F3Logic's Nuvation Bio position peaked at $109K in Q3 2021.
  • 105 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2021.

Based on F3Logic's 13F filing for Q4 2021, filed 4 Feb 2022.